-
Add to Cart The item has been addedP406590-10UProduct DescriptionInorganic pyrophosphatase (PPase) can catalyze the hydrolysis of inorganic pyrophosphate to orthophosphate: P2O74-+H2O+PPase→2HPO42-. Used in nucleic acid amplification experiments, PPase can hydrolyze the inorganic pyrophosphate -
Add to Cart The item has been addedR659477-100mgRdRP-IN-2 is a RNA dependent RNA polymerase (RdRp) inhibitor. RdRP-IN-2 significantly inhibits SARS-CoV-2 RdRp with an IC 50 of 41.2 µM.RdRP-IN-2 also inhibits Feline coronavirus (FIPV) replication.Appearance:SolidIn Vitro:RdRP-IN-2 (Compound 17) -
Add to Cart The item has been addedR659477-10mgRdRP-IN-2 is a RNA dependent RNA polymerase (RdRp) inhibitor. RdRP-IN-2 significantly inhibits SARS-CoV-2 RdRp with an IC 50 of 41.2 µM.RdRP-IN-2 also inhibits Feline coronavirus (FIPV) replication.Appearance:SolidIn Vitro:RdRP-IN-2 (Compound 17) -
Add to Cart The item has been addedR659477-25mgRdRP-IN-2 is a RNA dependent RNA polymerase (RdRp) inhibitor. RdRP-IN-2 significantly inhibits SARS-CoV-2 RdRp with an IC 50 of 41.2 µM.RdRP-IN-2 also inhibits Feline coronavirus (FIPV) replication.Appearance:SolidIn Vitro:RdRP-IN-2 (Compound 17) -
Add to Cart The item has been addedR659477-50mgRdRP-IN-2 is a RNA dependent RNA polymerase (RdRp) inhibitor. RdRP-IN-2 significantly inhibits SARS-CoV-2 RdRp with an IC 50 of 41.2 µM.RdRP-IN-2 also inhibits Feline coronavirus (FIPV) replication.Appearance:SolidIn Vitro:RdRP-IN-2 (Compound 17) -
Add to Cart The item has been addedR659477-5mgRdRP-IN-2 is a RNA dependent RNA polymerase (RdRp) inhibitor. RdRP-IN-2 significantly inhibits SARS-CoV-2 RdRp with an IC 50 of 41.2 µM.RdRP-IN-2 also inhibits Feline coronavirus (FIPV) replication.Appearance:SolidIn Vitro:RdRP-IN-2 (Compound 17) -
Add to Cart The item has been addedR661716-1mlRdRP-IN-2 is a RNA dependent RNA polymerase (RdRp) inhibitor. RdRP-IN-2 significantly inhibits SARS-CoV-2 RdRp with an IC 50 of 41.2 µM.RdRP-IN-2 also inhibits Feline coronavirus (FIPV) replication.In Vitro:RdRP-IN-2 (Compound 17) completely -
Add to Cart The item has been addedS651808-10mgSARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases.Form:Solid -
Add to Cart The item has been addedS651808-25mgSARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases.Form:Solid -
Add to Cart The item has been addedS651808-5mgSARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases.Form:Solid -
Add to Cart The item has been addedS647437-100mgSARS-CoV-2-IN-13 (compound 5) is a potent inhibitor of SARS-CoV-2 with an IC 50 of 0.057 μM. SARS-CoV-2-IN-13 is a niclosamide analogue. SARS-CoV-2-IN-13 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which -
Add to Cart The item has been addedS647437-10mgSARS-CoV-2-IN-13 (compound 5) is a potent inhibitor of SARS-CoV-2 with an IC 50 of 0.057 μM. SARS-CoV-2-IN-13 is a niclosamide analogue. SARS-CoV-2-IN-13 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which
